Nanjing Lambert Aix Biotechnology Co., Ltd. (referred to as Lambert Aix) was established in July 2020. The company relies on its own research and development system to cooperate with major universities in China, gathering numerous elites in the biotechnology industry. Among them, R&D personnel account for 60%, and personnel with bachelor's degrees or above account for 100%.

Lambert Aix focuses on the research and production of intelligent equipment and instruments in biological and medical laboratories, as well as the development and production of experimental reagents, gradually forming a comprehensive industrial platform integrating research and development, production, and training with biotechnology as the main focus. We provide cutting-edge technology research and development services and overall solutions for the industry, as well as highly intelligent, standardized, and IoT enabled equipment systems, to support the development and social progress of the biomedical field.